Skip to main content

Follow us

Home

Search

the Gateway to Research in Oklahoma

  • Researchers
  • Providers
  • Patients
  • About GRO

Gateway to Research in Oklahoma


Oklahoma Shared Clinical and Translational Resources U54 GM104938

Researchers

imgResearchers

The GRO: Researcher Portal provides resources, information, and training to help individuals or communities involved in performing clinical and translational research in Oklahoma.

Providers

imgProviders

The GRO: Provider Portal assists medical providers to identify clinical research opportunities in Oklahoma, tools for patient education, and evidence-based resources to improve patient care.

Patients

imgPatients

The GRO: Patient Portal can help patients and families to learn more about clinical and translational research and to connect with opportunities to participate in research opportunities in your communities.

Oklahoma Research Highlights

QcrB inhibitor Q203 (Telacebec) can synergize with clofazimine and clarithromycin to control a Mycobacterium avium infection

1 week 5 days ago
The targeting of the mycobacterial electron transport chain for drug development has recently garnered significant clinical success. The cytochrome bcc complex within the electron transport chain has emerged as a viable drug target, with the antibiotic Q203 (Telacebec) showing excellent activity against M. tuberculosis in vitro and in vivo. To determine if Q203 can function as an antibiotic against the non-tuberculosis mycobacteria M. avium and M. intracellulare (MAC), MIC and bactericidal...
Yong Cheng

Concurrent SVT and atrial fibrillation ablation using a dual-energy linear ablation catheter

1 week 5 days ago
No abstract
Sri Sundaram

A Call to Reform Congenital Interventional Cardiology Training: A PICES Community Survey

1 week 5 days ago
No abstract
Stephen Nageotte

Resting Energy Expenditure is Overpredicted in Midlife Females: Examining the Accuracy of Predictive Equations and the Role of Lean Soft Tissue in Perimenopause

1 week 5 days ago
CONCLUSIONS: Estimated REE significantly overestimated caloric expenditure compared to mREE by an average of ∼215 kcals/day, with some equations (MS, M) more accurately estimating REE in perimenopausal women. The MS equation may be most beneficial for REE estimates in midlife women. LST may not be driving differences between mREE and predictive equations.
Gabrielle M DelBiondo

Insulin resistance: current methods of predicting and need for improved models

1 week 5 days ago
No abstract
Rachana Shah

Pagination

  • Previous page ‹ Previous
  • Page 192
  • Next page Next ›
Subscribe to

octsi logo

1000 N. Lincoln Blvd, Suite 2100, Oklahoma City, OK 73104
Copyright © 2021 The Board of Regents of the University of Oklahoma, All Rights Reserved.

About GRO

News
Publications
FAQ

Terms of Use

Privacy Policy
Accessibility

Contact

info email
info phone
Copyright © 2026. All rights reserved. Designed By Zymphonies